Plasencia-Rodríguez, Chamaida https://orcid.org/0000-0003-3503-9047
Martínez-Feito, Ana
Hernández, Marta
Del Pino-Molina, Lucia
Novella-Navarro, Marta
Serrano, Yolanda
González-Muñoz, Miguel
Peiteado, Diana
Bonilla, Gema
Monjo, Irene
Nuño, Laura
Tornero, Carolina
López-Granados, Eduardo
Balsa, Alejandro
Nozal, Pilar
Article History
Received: 24 April 2023
Accepted: 6 August 2023
First Online: 19 August 2023
Declarations
:
: This study has been approved by the ethics committee (PI-4101) and the patients have been informed and have signed the informed consent for their participation.
: We have signed a consent for publication (see Additional file ).
: CPR and IM report grants from Abbvie, Pfizer, Novartis, Lilly, Janssen, UCB, Amgen and Roche outside the submitted work. MNN reports grants from UCB, Lilly and Janssen outside the submitted work. AB reports grants form Abbvie, Amgen, Pfizer, Galapagos, Novartis, Gilead, BMS, Nordic, Sanofi, Sandoz, Lilly, UCB and Roche outside the submitted work. DP reports grants from Abbvie, Pfizer, Novartis, Janssen, Lilly and UCB outside the submitted work. GB reports grants from Abbvie, Pfizer, Lilly and Roche outside the submitted work. CT reports grants from Abbvie, Pfizer, Novartis, Lilly and UCB outside the submitted work. LN, AMF, LPM, PN, YS, MGM, ELG, MD and MDA declare no competing interests.